Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07674680
EARLY_PHASE1
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
Sponsor: University of Missouri-Columbia
View on ClinicalTrials.gov
Summary
We hypothesize vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
Key Details
Gender
FEMALE
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-07
Completion Date
2029-05
Last Updated
2026-06-29
Healthy Volunteers
Yes
Interventions
DRUG
Placebo
Participants will receive a placebo in pill form.
DRUG
Gemtesa
Participants will receive oral gemtesa (75 mg).
Locations (1)
University of Missouri
Columbia, Missouri, United States